by Peter Ciszewski | May 19, 2018
Yuval Cohen, PhD, CEO of Corbus discusses the role of inflammation in auto-immune diseases. Inflammation occurs when our immune system, designed to protect our bodies from external pathogens, is activated. Under normal circumstances, once it has been activated and the...
by Peter Ciszewski | May 18, 2018
Chris Garabedian discusses some of Xontogeny’s recent activity. Xontogeny is a biotech aggregator which supports the accelerated development of life science technologies in the pursuit of helping patients with serious...
by Peter Ciszewski | May 17, 2018
Rob Neville of Savara Pharmaceuticals discusses how his company engages advocacy groups in the disease they have clinical programs in, including PAP and Cystic...
by Peter Ciszewski | May 16, 2018
Seth Rotberg, 27, was diagnosed with Huntington’s Disease at age 20 and has since become an advocate for rare disease patients. He tells us about his experience dealing with his own diagnosis, and shares his advice for anyone dealing with a new disease diagnosis,...
by Peter Ciszewski | May 16, 2018
Albireo Pharma announced that the first patient has been enrolled, a Phase 3 clinical trial (called PEDFIC-1) for patients with progressive familial intrahepatic cholestasis (PFIC), a rare and progressive liver disease, which typically leads to liver failure. In...
